With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Bristol Myers Squibb’s Opdivo plus Yervoy, as well as Pfizer’s Braftovi, have each shown strong Phase III performances that ...

Where can researchers look for a beacon of hope amid trying times in the pharmaceutical industry? Read on for answers.

There are 20 cell and gene therapies on Europe's market versus 43 in the U.S. Find out more about this ecosystem.

Achondroplasia, which affects around one in 20,000 babies, has just one approved treatment: BioMarin’s Voxzogo. However, new investigational treatments are vying to compete in the area.